Know Labs Inc (KNW)

[RMacchio]

If it's based on Libra then it still requires a patch with needle stuck on the body. It will also have to be changed every few weeks and will cost at least $2K/year to use. The UBAND would be a superior solution... But I agree with others that KNWN's competitive advantage is slowly (or quickly) eroding as they drag their feet on getting the device out.

I first started investing in mid-2018 when they were about to release the calorie counter which was the first application that would be used to fund the CGM development.

They changed priorities, scrapping the calorie counter, and in Jan 2019 presented at the JP Morgan Biotech conference where they planned to have the CGM development complete by the end of 2019. Here we are more than a year later waiting for the Frankenstein prototype which will be followed some months later by a working model.

This may end up being a stock you pass to your kids and grandkids telling them that it might be worth something some day when they finally get it working.